SNGX
SNGX
NASDAQ · Biotechnology

Soligenix Inc

$0.32
+0.00 (+0.37%)
Analyst Consensus
Strong Buy
7
Analysts
Moderate
Coverage
Buy 6 86%
Hold 1 14%
Sell 0 0%
Price Target
Analyst Price Target +12,607.7% upside
Low Target $24.77
Average Target $40.83
High Target $47.84
Current Price $0.32
Current
$0.32
Target
$40.83
$24.77 $40.83 avg $47.84
Scenario Analysis
Bear Case
$24.77
7,609.3%
Low target
Base Case
$40.83
+12,607.7%
Avg target
Bull Case
$47.84
+14,789.5%
High target
Risk/Reward
1.9x
Balanced
Price in Context
52-Week High
$1.70
-81.0% from high
52-Week Low
$0.28
+14.8% from low
Target vs 52W High
$40.83
+2,308.8% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 38 82% $257.58 -12.5%
AMGN
Amgen Inc
Hold 42 43% $190.87 -59.0%
GILD
Gilead Sciences Inc
Strong Buy 36 83% $362.68 +115.4%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 39 82% $438.34 -18.5%
MRNA
Moderna Inc
Hold 31 32% $149.45 -35.4%
REGN
Regeneron Pharmaceuticals
Buy 36 72% $76.80 -91.9%
NTRA
Natera Inc
Strong Buy 31 90% $142.91 -55.7%
RVMD
Revolution Medicines Inc
Strong Buy 31 94% $114.11 -35.3%